109 related articles for article (PubMed ID: 29207595)
1. CDK1 promotes nascent DNA synthesis and induces resistance of cancer cells to DNA-damaging therapeutic agents.
Liao H; Ji F; Geng X; Xing M; Li W; Chen Z; Shen H; Ying S
Oncotarget; 2017 Oct; 8(53):90662-90673. PubMed ID: 29207595
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent kinase 1 plays a critical role in DNA replication control during rat liver regeneration.
Garnier D; Loyer P; Ribault C; Guguen-Guillouzo C; Corlu A
Hepatology; 2009 Dec; 50(6):1946-56. PubMed ID: 19821535
[TBL] [Abstract][Full Text] [Related]
3. A role for the spindle assembly checkpoint in the DNA damage response.
Palou R; Palou G; Quintana DG
Curr Genet; 2017 May; 63(2):275-280. PubMed ID: 27488803
[TBL] [Abstract][Full Text] [Related]
4. Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC).
Wijnen R; Pecoraro C; Carbone D; Fiuji H; Avan A; Peters GJ; Giovannetti E; Diana P
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503199
[TBL] [Abstract][Full Text] [Related]
5. Forced activation of Cdk1 via wee1 inhibition impairs homologous recombination.
Krajewska M; Heijink AM; Bisselink YJ; Seinstra RI; Silljé HH; de Vries EG; van Vugt MA
Oncogene; 2013 Jun; 32(24):3001-8. PubMed ID: 22797065
[TBL] [Abstract][Full Text] [Related]
6. Identification of YPL014W (Cip1) as a novel negative regulator of cyclin-dependent kinase in Saccharomyces cerevisiae.
Ren P; Malik A; Zeng F
Genes Cells; 2016 Jun; 21(6):543-52. PubMed ID: 27005485
[TBL] [Abstract][Full Text] [Related]
7. An essential role for Cdk1 in S phase control is revealed via chemical genetics in vertebrate cells.
Hochegger H; Dejsuphong D; Sonoda E; Saberi A; Rajendra E; Kirk J; Hunt T; Takeda S
J Cell Biol; 2007 Jul; 178(2):257-68. PubMed ID: 17635936
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the DNA damage response by cyclin-dependent kinases.
Trovesi C; Manfrini N; Falcettoni M; Longhese MP
J Mol Biol; 2013 Nov; 425(23):4756-66. PubMed ID: 23603016
[TBL] [Abstract][Full Text] [Related]
9. Role of Cdk1 in the p53-independent abrogation of the postmitotic checkpoint by human papillomavirus E6.
Zhang W; Liu Y; Zhao N; Chen H; Qiao L; Zhao W; Chen JJ
J Virol; 2015 Mar; 89(5):2553-62. PubMed ID: 25520504
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of human Fen1 by cyclin-dependent kinase modulates its role in replication fork regulation.
Henneke G; Koundrioukoff S; Hübscher U
Oncogene; 2003 Jul; 22(28):4301-13. PubMed ID: 12853968
[TBL] [Abstract][Full Text] [Related]
11. The CDK1 inhibitor RO3306 improves the response of BRCA-proficient breast cancer cells to PARP inhibition.
Xia Q; Cai Y; Peng R; Wu G; Shi Y; Jiang W
Int J Oncol; 2014 Mar; 44(3):735-44. PubMed ID: 24378347
[TBL] [Abstract][Full Text] [Related]
12. Two Distinct Cdc2 Pools Regulate Cell Cycle Progression and the DNA Damage Response in the Fission Yeast S.pombe.
Caspari T; Hilditch V
PLoS One; 2015; 10(7):e0130748. PubMed ID: 26131711
[TBL] [Abstract][Full Text] [Related]
13. Srs2 DNA helicase is involved in checkpoint response and its regulation requires a functional Mec1-dependent pathway and Cdk1 activity.
Liberi G; Chiolo I; Pellicioli A; Lopes M; Plevani P; Muzi-Falconi M; Foiani M
EMBO J; 2000 Sep; 19(18):5027-38. PubMed ID: 10990466
[TBL] [Abstract][Full Text] [Related]
14. Sic1 as a timer of Clb cyclin waves in the yeast cell cycle--design principle of not just an inhibitor.
Barberis M
FEBS J; 2012 Sep; 279(18):3386-410. PubMed ID: 22356687
[TBL] [Abstract][Full Text] [Related]
15. Cdk2 activity is dispensable for the onset of DNA replication during the first mitotic cycles of the sea urchin early embryo.
Moreau JL; Marques F; Barakat A; Schatt P; Lozano JC; Peaucellier G; Picard A; Genevière AM
Dev Biol; 1998 Aug; 200(2):182-97. PubMed ID: 9705226
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of trophoblast stem cells into giant cells is triggered by p57/Kip2 inhibition of CDK1 activity.
Ullah Z; Kohn MJ; Yagi R; Vassilev LT; DePamphilis ML
Genes Dev; 2008 Nov; 22(21):3024-36. PubMed ID: 18981479
[TBL] [Abstract][Full Text] [Related]
17. The newly synthesized 2-arylnaphthyridin-4-one, CSC-3436, induces apoptosis of non-small cell lung cancer cells by inhibiting tubulin dynamics and activating CDK1.
Chang LC; Yu YL; Liu CY; Cheng YY; Chou RH; Hsieh MT; Lin HY; Hung HY; Huang LJ; Wu YC; Kuo SC
Cancer Chemother Pharmacol; 2015 Jun; 75(6):1303-15. PubMed ID: 25947085
[TBL] [Abstract][Full Text] [Related]
18. Artemis links ATM to G2/M checkpoint recovery via regulation of Cdk1-cyclin B.
Geng L; Zhang X; Zheng S; Legerski RJ
Mol Cell Biol; 2007 Apr; 27(7):2625-35. PubMed ID: 17242184
[TBL] [Abstract][Full Text] [Related]
19. The single Cdk1-G1 cyclin of Cryptococcus neoformans is not essential for cell cycle progression, but plays important roles in the proper commitment to DNA synthesis and bud emergence in this yeast.
Virtudazo EV; Kawamoto S; Ohkusu M; Aoki S; Sipiczki M; Takeo K
FEMS Yeast Res; 2010 Aug; 10(5):605-18. PubMed ID: 20528951
[TBL] [Abstract][Full Text] [Related]
20. The checkpoint 1 kinase inhibitor LY2603618 induces cell cycle arrest, DNA damage response and autophagy in cancer cells.
Wang FZ; Fei HR; Cui YJ; Sun YK; Li ZM; Wang XY; Yang XY; Zhang JG; Sun BL
Apoptosis; 2014 Sep; 19(9):1389-98. PubMed ID: 24928205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]